MC
CRTX

Menta Capital’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Menta Capital’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,903
Closed -$151K – 526
2013
Q2 		$151K Buy
+18,903
New +$159K 0.1% 354

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Menta Capital's CRTX Position: Q3 2013 in Review

Menta Capital sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q3 2013, closing a stake of 18,903 shares — an estimated $151K sold.

Menta Capital first reported a position in CRTX in Q2 2013 and held it in 1 quarter. The position peaked at $151K in Q2 2013. 64 funds tracked by Wall St. Rank hold CRTX as of Q3 2013.

  • Menta Capital reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q3 2013 after selling out during the quarter.
  • Menta Capital sold 18,903 CORNERSTONE THERAPEUTICS INC shares in Q3 2013, an estimated $151K.
  • Menta Capital first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 1 quarter.
  • Menta Capital's CORNERSTONE THERAPEUTICS INC position peaked at $151K in Q2 2013.
  • 64 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q3 2013.

Based on Menta Capital's 13F filing for Q3 2013, filed 5 Nov 2013.